Clinical Trial Update: Real Life Dosing of Remicade for Rheumatoid Arthritis in Austria Monitored Over 9 Infusions (Study P03756)(COMPLETED)

View source ↗

Summary

Real-world dosing study of Remicade (infliximab) for rheumatoid arthritis in Austria, monitored across nine infusions; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Rheumatoid Arthritis | Status: COMPLETED | Results posted: 2011-08-04